Form 4 for RARE Ultragenyx Pharmaceutical Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026672 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-03-05	2024-03-01	RARE	Horn Howard	CFO	A - Grant	$0.00	+19.4K	99.8K	+24%	$0
D	2024-03-05	2024-03-01	RARE	Horn Howard	CFO	A - Grant	$0.00	+34.2K	34.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-03-01	A	A	19,400	$0.00	99,766	D	—	—	(F1) Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the "October 2023 Form 4"). The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366.
2	Derivative	Stock Option (Right to Buy)	2024-03-01	A	A	34,200	$0.00	34,200	D	$53.69 · — to 2034-03-01	34,200 Common Stock	(F3) On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.